Shineco, Inc. (NASDAQ: SISI) is a diversified holding company that has recently undergone a strategic transformation, positioning itself for long-term success. With a focus on innovative products, strategic acquisitions, and expanding its footprint, SISI is emerging as a promising player in the healthcare, agricultural, and consumer sectors.
Business Overview
SISI operates through three main business segments: Rapid Diagnostic and Other Products, Other Agricultural Products, and Healthy Meals Products. The Rapid Diagnostic and Other Products segment, conducted through the company's subsidiary Biowin, specializes in the development, production, and distribution of innovative rapid diagnostic products and related medical devices. The Other Agricultural Products segment, operated by Wintus, engages in the production, processing, and distribution of agricultural products such as silk, silk fabrics, and fresh fruit. The Healthy Meals Products segment, led by Fuzhou Meida, operates a health-oriented chain restaurant that focuses on developing healthy meals for people with slow metabolic health and those in recovery from metabolic disorders.Financials
In the latest fiscal year, SISI reported annual revenue of $550,476 and a net loss of $13,363,399. The company's annual operating cash flow was -$5,390,594, and its annual free cash flow was -$5,409,440. While the company has faced some financial challenges, its recent strategic initiatives and acquisitions suggest a promising path forward.For the first nine months of the current fiscal year, SISI reported revenue of $5,304,159, a significant increase from the $231,513 reported in the same period of the previous year. This growth was primarily driven by the contributions from the company's newly acquired subsidiaries, Biowin and Wintus. Gross profit for the nine-month period was $602,940, compared to $11,156 in the prior-year period.
The company's net loss from continuing operations for the nine-month period was $12,937,954, compared to a net loss of $6,886,985 in the same period of the previous year. The increase in net loss was primarily due to higher general and administrative expenses, which rose to $12,155,801 from $5,986,324 in the prior-year period. This was partially offset by a benefit for income taxes of $460,039, compared to a benefit of $33,089 in the same period of the previous year.
Quarterly Performance
In the most recent quarter, SISI reported revenue of $1,351,400, a significant increase from the $231,513 reported in the same quarter of the previous year. Gross profit for the quarter was $191,667, compared to $11,156 in the prior-year quarter.The company's net loss from continuing operations for the quarter was $4,368,728, compared to a net loss of $2,939,166 in the same quarter of the previous year. The increase in net loss was primarily due to higher general and administrative expenses, which rose to $3,304,426 from $2,691,544 in the prior-year quarter.
Segmental Performance
Rapid Diagnostic and Other Products Segment
The Rapid Diagnostic and Other Products segment, operated by Biowin, reported revenue of $441,927 for the first nine months of the current fiscal year, compared to $231,513 in the same period of the previous year. Gross profit for this segment was $271,973, compared to $11,156 in the prior-year period. The increase in revenue and gross profit was primarily due to the nine-month contribution from Biowin, as the company acquired the subsidiary in January 2023.Other Agricultural Products Segment
The Other Agricultural Products segment, operated by Wintus, reported revenue of $4,844,587 for the first nine months of the current fiscal year. This segment did not contribute any revenue in the same period of the previous year, as Wintus was acquired by SISI in September 2023. Gross profit for this segment was $356,501.Healthy Meals Products Segment
The Healthy Meals Products segment, operated by Fuzhou Meida, reported revenue of $17,645 for the first nine months of the current fiscal year. This segment did not contribute any revenue in the same period of the previous year, as Fuzhou Meida was recently established by SISI. Gross loss for this segment was $25,534, as the company continues to invest in the development of this new business line.
Discontinued Operations
Due to the acquisition of Wintus, SISI's previous business segments, including Luobuma products, Other Agricultural Products, and Freight Services, have been reclassified as discontinued operations. These discontinued operations reported a net income of $8,855,247 for the first nine months of the current fiscal year, compared to a net loss of $937,831 in the same period of the previous year.Liquidity
As of March 31, 2024, SISI had cash and cash equivalents of $565,483, compared to $14,166,759 as of June 30, 2023. The company had $13.4 million in short-term loans and $1.7 million in long-term loans outstanding as of March 31, 2024. Management believes that the company's current cash, cash flows from future operations, and access to loans will be sufficient to meet its working capital needs for at least the next 12 months.SISI has also been active in raising capital through the issuance of common stock. In the most recent quarter, the company entered into a securities purchase agreement with certain non-US investors, under which it agreed to sell up to 285,714 shares of its common stock for gross proceeds of up to $285,714. The company has received the full proceeds from this transaction as of March 31, 2024.